Asthma
Conditions
Brief summary
To determine the additional effects of scalene hold relax technique with conventional exercises on pulmonary function in asthma patients
Interventions
OTHERScalene Hold Relax Technique
Scalene Hold Relax Technique Scalene Hold for 10 Second 10 Repetition. Hold your arms behind your back to keep them from rising then slowly tilt your head trying to touch your ear to your shoulder. Bend your neck only as far as it is comfortable, and hold for 5 to 10 seconds. Relax your neck and repeat 2-3 times on each side. The treatment will be provided for 1-4 weeks as per need
OTHERConventional Physical Therapy
Diaphragmatic Breathing Exercise Inhale through nose about 4 Seconds, hold Breath for 2 Seconds, repeat 5 times, exercise repeated for 2-3 days per week followed up to 4 weeks. \+ Buteyko Breathing Exercise Exhale slowly and then hold that breath. Use index figure and thumb to plug nose hold that breath until there is an urge to breathe and then inhale Breathe normally at least 10 second repeat several. Frequency 2-3 days per week with Moderate Intensity follow-up to 4weeks
Sponsors
Riphah International University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
22 Years to 44 Years
Healthy volunteers
Yes
Inclusion criteria
* Patient diagnosed with Allergic asthma * Both male and female will be included * Age between 20 to 44 years.
Exclusion criteria
* Patient who do not provide consent * Patient with any comorbid condition such as cardiovascular disease diabetes or other chronic illness * Patient with any psychological condition that may interfere with participation or adherence to the study protocol
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Asthma Control Questionnaire | 4 week | A simple questionnaire Objective to measure the adequacy of asthma control and change in asthma control which occur either spontaneously or as a result of treatment ACQ has multidimensional construct assessing symptoms (5 items -self-administering and rescue in bronchodilator use (1 item-self-administered and FEV1%(1 item completed by clinic staff Test Retest reproducibility Reported with high intraclass correlation coefficient =0.90 Internal Consistency yes 7 point scale (0=no impairment =6 maximum impairment for symptoms and rescue use and 7categories for FEV1%) Minimally imp difference Change in score 0.5 7 items (score Range 0 (Totally controlled and 6 Severely Uncontrolled) |
| Asthma Control Test | 4 week | A patient self-administered tool for identifying those with poorly controlled asthma assess the frequency of shortness of breath and general asthma The Score Range from 5 (poor control of asthma) to 25 complete control of asthma) with higher scores reflecting greater asthma control. 5 items with 4-week recall on symptoms and daily functioning 5-point scale for symptom and activities 1=not controlled at all 5= completely controlled |
| Lara Asthma Symptoms Scale | 4 week | The Lara Asthma Symptom Scale (LASS) is a validated tool designed to assess asthma symptoms in adults. It comprises eight questions that evaluate the frequency of various asthma-related symptoms over the past four weeks. Each question is scored on a 5-point Likert scale, where higher scores indicate more frequent symptoms. To interpret the LASS, sum the scores from all eight questions to obtain a total score ranging from 0 to 32. Higher total scores indicate more frequent and severe asthma symptoms, suggesting poorer asthma control. |
| FEV1 | 4 week | Forced Expiratory Volume in 1 second, is a measurement of how much air a person can forcefully exhale from their lungs in one second. |
| FVC | 4 week | Forced Vital Capacity, is a measurement of lung function assessed during spirometry. t represents the maximum amount of air that can be forcefully exhaled after a full inhalation. |
| PEF | 4 week | Peak Expiratory Flow) spirometer, often a simple peak flow meter, is a device used to measure the speed of air exhaled from the lungs. |
Countries
Pakistan
Contacts
Primary ContactMuhammad Iqbal Tariq, PhD*
Outcome results
None listed